Comprehensive Therapy to Relieving the Risk of Recurrence and Metastasis for Colorectal Cancer
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Colorectal Cancer
Related studies linked through entity extraction aliases.
S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis
- Status
- COMPLETED
- Phase
- PHASE1
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers
- Status
- COMPLETED
- Phase
- N/A
Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
Trial of Second Generation Designer T Cells in Colorectal Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Interactive Computer Program or Brochure in Increasing Colorectal Cancer Screening Among African Americans
- Status
- COMPLETED
- Phase
- NA
A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy of the Third Eye Retroscope Auxiliary Imaging System
- Status
- COMPLETED
- Phase
- NA
Focusing Implementation to Bring Effective Reminders (FIBER)
- Status
- COMPLETED
- Phase
- NA
Study of Colon GVAX and Cyclophosphamide in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2